Brown, Lisle/Cummings, Inc. Adaptive Biotechnologies Corp Transaction History
Brown, Lisle/Cummings, Inc.
- $329 Billion
- Q3 2024
A detailed history of Brown, Lisle/Cummings, Inc. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Brown, Lisle/Cummings, Inc. holds 200 shares of ADPT stock, worth $1,300. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$1,300
Previous $724,000
41.44%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ADPT
# of Institutions
204Shares Held
146MCall Options Held
68.8KPut Options Held
42.5K-
Viking Global Investors LP30MShares$195 Million0.59% of portfolio
-
Rubric Capital Management LP New York, NY14.4MShares$93.6 Million2.05% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$75.8 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.6MShares$75.4 Million0.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$69.2 Million0.0% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $929M
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...